… We have summarized the pharmacological therapies on cardiac remodeling after AMI (Table
1). Firstly, the complex pathophysiological processes of cardiac remodeling were …

… cardiac remodeling. In particular, ACE inhibition, beta-blockade and aldosterone antagonism
have proven to be effective in modulating the process of remodeling … modulate remodeling, …

… and clinical implications of cardiac remodeling, and the … the pharmacological treatment
of cardiac remodeling, which … Besides, modulation of the adaptive response (macrophages…

… regulation of transcription factors or by modulation of transcriptional accessory proteins.
For … Similarly, short-term pharmacological inhibition of the conventional PKC isoforms (including …

… patients with cardiac failure. It has been recently shown that AT2R pharmacologic agonism
… performance, contributing to cardioprotection by increasing the cardiac c-kit+AT2+ cell …

… cardiac remodeling and the mechanisms of potential beneficial effects of statins on cardiac
remodeling… Cardiac remodeling can occur following any form of cardiac injury, but most of our …

… discuss data derived from gene therapy approaches for modulating key mediators of cardiac
remodeling. … At the same time, pharmacological inhibition of fatty acid oxidation ameliorates …

… The pharmacological modulation of cardiac hypertrophy by such agents as clenbuterol
may improve our understanding of the different mechanisms in cardiac hypertrophy and have …

… Cardiac remodeling is generally accepted as a determinant … resulting from cardiac load or
injury, cardiac remodeling is … in mitral insufficiency, modulate remodeling of the ventricle to …

… NO serves several important physiological roles in the regulation of cardiac function, …
activation, modulation of cardiac contractile function, and inhibition of cardiac oxygen consumption (…